-
William Blair Reaffirms "Outperform" Rating for Verve Therapeutics (NASDAQ:VERV)
Источник: Buzz FX / 22 фев 2025 22:26:17 America/New_York
William Blair Reaffirms "Outperform" Rating for Verve Therapeutics (NASDAQ:VERV) Written by MarketBeat February 22, 2025 Share Link copied to clipboard. Verve Therapeutics ( NASDAQ:VERV - Get Free Report ) 's stock had its "outperform" rati
Read more...